Nussbaum Robert L 4
4 · Invitae Corp · Filed Mar 16, 2022
Insider Transaction Report
Form 4
Invitae CorpNVTA
Nussbaum Robert L
Chief Medical Officer
Transactions
- Award
Common Stock
2022-03-12+14,705→ 260,755 total - Sale
Common Stock
2022-03-14$6.69/sh−19,588$130,993→ 241,167 total
Footnotes (4)
- [F1]Shares issued upon settlement of a restricted stock unit award that vests in two equal installments, with 1/2 of the remaining award vesting on March 12, 2023, subject to continued service with the issuer through such vesting date.
- [F2]Includes an aggregate of 91,486 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
- [F3]Represents the sale of shares to cover tax withholding obligations associated with the vesting and settlement of restricted stock units.
- [F4]Represents a weighted average sale price. Actual sale prices ranged from $6.6873 to $6.6876 per share. The reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.